Arbor Biotechnologies

About:

Arbor Biotechnologies is an operator of a bio-discovery company intended to provide human diagnostic development services.

Website: https://arbor.bio/

Top Investors: Temasek Holdings, ARCH Venture Partners, Deep Track Capital, Section 32, T. Rowe Price

Description:

Arbor Biotechnologies is an operator of a bio-discovery company intended to provide human diagnostic development services. The company's platform employs a diverse set of technologies and techniques including artificial intelligence, genome sequencing, gene synthesis, and high-throughput screening, enabling drug developers to accelerate the discovery of proteins for improving human health and sustainability.

Total Funding Amount:

$231M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2016-01-01

Contact Email:

press(AT)arbor.bio

Founders:

David R. Walt, David Scott, Feng Zhang, Winston Yan

Number of Employees:

51-100

Last Funding Date:

2021-11-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai